Credit Suisse’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-9,331
| Closed | -$113K | – | 3136 |
|
|
2023
Q2 | $113K | Sell |
9,331
-2,763
| -23% | -$33.5K | ﹤0.01% | 3116 |
|
|
2023
Q1 | $154K | Hold |
12,094
| – | – | ﹤0.01% | 3146 |
|
|
2022
Q4 | $76.4K | Hold |
12,094
| – | – | ﹤0.01% | 3349 |
|
|
2022
Q3 | $273K | Sell |
12,094
-1
| -0% | -$23 | ﹤0.01% | 3102 |
|
|
2022
Q2 | $232K | Sell |
12,095
-48
| -0.4% | -$921 | ﹤0.01% | 3261 |
|
|
2022
Q1 | $563K | Sell |
12,143
-8
| -0.1% | -$371 | ﹤0.01% | 2887 |
|
|
2021
Q4 | $861K | Buy |
12,151
+2,378
| +24% | +$169K | ﹤0.01% | 2679 |
|
|
2021
Q3 | $1.14M | Buy |
9,773
+7,159
| +274% | +$834K | ﹤0.01% | 2495 |
|
|
2021
Q2 | $409K | Sell |
2,614
-81
| -3% | -$12.7K | ﹤0.01% | 3125 |
|
|
2021
Q1 | $510K | Sell |
2,695
-932
| -26% | -$176K | ﹤0.01% | 2939 |
|
|
2020
Q4 | $455K | Buy |
3,627
+191
| +6% | +$24K | ﹤0.01% | 3017 |
|
|
2020
Q3 | $374K | Buy |
3,436
+2,168
| +171% | +$236K | ﹤0.01% | 2807 |
|
|
2020
Q2 | $152K | Buy |
1,268
+140
| +12% | +$16.8K | ﹤0.01% | 3147 |
|
|
2020
Q1 | $113K | Buy |
+1,128
| New | +$113K | ﹤0.01% | 3184 |
|